# Test, Factor V Leiden Mutations, Genomic Dna Pcr
> **Product code: NPQ** · Class II — Moderate Risk (510(k) clearance required) · Hematology · 21 CFR 864.7280
## Classification
- **FDA Product Code:** NPQ
- **Device class:** Class II — Moderate Risk (510(k) clearance required)
- **Regulation:** 21 CFR 864.7280
- **Review panel:** PA
- **Medical specialty:** Hematology
- **Submission type:** 1
- **GMP exempt:** N
- **Life sustaining:** N
- **Implant:** N
- **Third-party review:** N
## Definition

In vitro diagnostic test to detect the Factor V Leiden mutation in genomic DNA, as an aid to diagnosis in the evaluation of patients with suspected thrombophilia.

## Market data
- **Cleared 510(k) submissions:** 6
- **Registered establishments:** 4
## Source
- [FDA Device Classification](https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpcd/classification.cfm?ID=NPQ)
---
*AI Analytics · CC0 1.0*